Chandran, S., Leung, J., Hu, C., Laszik, Z. G., Tang, Q., & Vincenti, F. G. (2021). Interleukin‐6 blockade with tocilizumab increases Tregs and reduces T effector cytokines in renal graft inflammation: A randomized controlled trial. American journal of transplantation, 21(7), 2543-2554. https://doi.org/10.1111/ajt.16459
Chicago Style (17th ed.) CitationChandran, Sindhu, Joey Leung, Crystal Hu, Zoltan G. Laszik, Qizhi Tang, and Flavio G. Vincenti. "Interleukin‐6 Blockade with Tocilizumab Increases Tregs and Reduces T Effector Cytokines in Renal Graft Inflammation: A Randomized Controlled Trial." American Journal of Transplantation 21, no. 7 (2021): 2543-2554. https://doi.org/10.1111/ajt.16459.
MLA (9th ed.) CitationChandran, Sindhu, et al. "Interleukin‐6 Blockade with Tocilizumab Increases Tregs and Reduces T Effector Cytokines in Renal Graft Inflammation: A Randomized Controlled Trial." American Journal of Transplantation, vol. 21, no. 7, 2021, pp. 2543-2554, https://doi.org/10.1111/ajt.16459.